163 related articles for article (PubMed ID: 1673316)
1. X chromosome inactivation in fibroblasts of mentally retarded female carriers of the fragile site Xq27.3: application of the probe M27 beta to evaluate X inactivation status.
Schmidt M; Du Sart D; Kalitsis P; Fraser N; Leversha M; Voullaire L; Foster D; Davies J; Hills L; Petrovic V
Am J Med Genet; 1991; 38(2-3):411-5. PubMed ID: 1673316
[TBL] [Abstract][Full Text] [Related]
2. Fragile X expression and X inactivation. II. The fragile site at Xq27.3 has a basic function in the pathogenesis of fragile X-linked mental retardation.
Wöhrle D; Steinbach P
Hum Genet; 1991 Aug; 87(4):421-4. PubMed ID: 1715307
[TBL] [Abstract][Full Text] [Related]
3. Fragile Xq27.3 in female heterozygotes for the Martin-Bell syndrome.
Webb T; Jacobs PA
J Med Genet; 1990 Oct; 27(10):627-31. PubMed ID: 2246771
[TBL] [Abstract][Full Text] [Related]
4. Effect of X inactivation on fragile X frequency and mental retardation.
Rosenberg C; Vianna-Morgante AM; Otto PA; Navajas L
Am J Med Genet; 1991; 38(2-3):421-4. PubMed ID: 2018084
[TBL] [Abstract][Full Text] [Related]
5. Fragile X expression and X inactivation. I. The expression of the fragile site at Xq27.3 is not suppressed on inactive X chromosomes separated from the active homologue.
Wöhrle D; Fryns JP; Steinbach P
Hum Genet; 1990 Oct; 85(6):659-65. PubMed ID: 2227957
[TBL] [Abstract][Full Text] [Related]
6. Unusual X chromosome inactivation in a mentally retarded girl with an interstitial deletion Xq27: implications for the fragile X syndrome.
Schmidt M; Certoma A; Du Sart D; Kalitsis P; Leversha M; Fowler K; Sheffield L; Jack I; Danks DM
Hum Genet; 1990 Mar; 84(4):347-52. PubMed ID: 2307456
[TBL] [Abstract][Full Text] [Related]
7. Relationship of expansion of CGG repeats and X-inactivation with expression of fra(X)(q27.3) in heterozygotes.
Mingroni-Netto RC; Fernandes JG; Vianna-Morgante AM
Am J Med Genet; 1994 Jul; 51(4):443-6. PubMed ID: 7943014
[TBL] [Abstract][Full Text] [Related]
8. The inactivation of the fragile X chromosome in female carriers of the Martin Bell syndrome as studied by two different methods.
Tuckerman E; Webb T
Clin Genet; 1989 Jul; 36(1):25-30. PubMed ID: 2766560
[TBL] [Abstract][Full Text] [Related]
9. Expression of the fragile site Xq27 in fibroblasts. II. Evidence for negative and positive clones from heterozygous females and possible relationship between frequency and phenotype.
Steinbach P; Barbi G; Baur S; Vogel W
Hum Genet; 1983; 64(3):279-82. PubMed ID: 6885072
[TBL] [Abstract][Full Text] [Related]
10. Dissociation between mental retardation and fragile site expression in a family with fragile X-linked mental retardation.
Voelckel MA; Mattei MG; N'Guyen C; Philip N; Birg F; Mattei JF
Hum Genet; 1988 Dec; 80(4):375-8. PubMed ID: 2904402
[TBL] [Abstract][Full Text] [Related]
11. The fragile X syndrome in a large family. III. Investigations on linkage of flanking DNA markers with the fragile site Xq27.
Veenema H; Carpenter NJ; Bakker E; Hofker MH; Ward AM; Pearson PL
J Med Genet; 1987 Jul; 24(7):413-21. PubMed ID: 2886667
[TBL] [Abstract][Full Text] [Related]
12. Mental retardation in heterozygotes for the fragile-X mutation: evidence in favor of an X inactivation-dependent effect.
Rocchi M; Archidiacono N; Rinaldi A; Filippi G; Bartolucci G; Fancello GS; Siniscalco M
Am J Hum Genet; 1990 Apr; 46(4):738-43. PubMed ID: 2316520
[TBL] [Abstract][Full Text] [Related]
13. Wiskott-Aldrich syndrome carrier detection with the hypervariable marker M27 beta.
de Saint Basile G; Notarangelo LD; Bonaiti-Pellié C; Doussau M; Prolini O; Craig IW; Ugazio A; Griscelli C; Fischer A
Hum Genet; 1992 May; 89(2):223-8. PubMed ID: 1350264
[TBL] [Abstract][Full Text] [Related]
14. Three families with high expression of a fragile site at Xq27.3, lack of anomalies at the FMR-1 CpG island, and no clear phenotypic association.
Oberlé I; Boué J; Croquette MF; Voelckel MA; Mattei MG; Mandel JL
Am J Med Genet; 1992 Apr 15-May 1; 43(1-2):224-31. PubMed ID: 1605195
[TBL] [Abstract][Full Text] [Related]
15. Carrier detection and X-inactivation studies in the fragile X syndrome. Cytogenetic studies in 63 obligate and potential carriers of the fragile X.
Nielsen KB; Tommerup N; Poulsen H; Jacobsen P; Beck B; Mikkelsen M
Hum Genet; 1983; 64(3):240-5. PubMed ID: 6885068
[TBL] [Abstract][Full Text] [Related]
16. Possible erasure of the imprint on a fragile X chromosome when transmitted by a male.
Laird CD
Am J Med Genet; 1991; 38(2-3):391-5. PubMed ID: 2018078
[TBL] [Abstract][Full Text] [Related]
17. Clonal analysis of human tumors with M27 beta, a highly informative polymorphic X chromosomal probe.
Fey MF; Peter HJ; Hinds HL; Zimmermann A; Liechti-Gallati S; Gerber H; Studer H; Tobler A
J Clin Invest; 1992 May; 89(5):1438-44. PubMed ID: 1349026
[TBL] [Abstract][Full Text] [Related]
18. Fragile X syndrome in an extended family with special reference to an affected male with Klinefelter syndrome.
Voelckel MA; Pellissier MC; Piquet C; N'Guyen C; Boccaccio I; Philip N; Mattei JF
Am J Med Genet; 1991; 38(2-3):374-7. PubMed ID: 1673314
[TBL] [Abstract][Full Text] [Related]
19. [Familial mental retardation and the fragile X syndrome].
Veenema H; Pelckmans AJ; Geraedts JP; Van Leeuwen I; Zvelebil N
Tijdschr Kindergeneeskd; 1984 Feb; 52(1):9-15. PubMed ID: 6585033
[TBL] [Abstract][Full Text] [Related]
20. Dermatoglyphic peculiarities in families with X-linked mental retardation and fragile site Xq27: a collaborative study.
Rodewald A; Froster-Iskenius U; Käb E; Langenbeck U; Schinzel A; Schmidt A; Schwinger E; Steinbach P; Veenema H; Wegner RD
Clin Genet; 1986 Jul; 30(1):1-13. PubMed ID: 3757292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
